US Stock MarketDetailed Quotes

AbbVie (ABBV)

Watchlist
  • 227.730
  • +2.960+1.32%
Close Jun 12 16:00 ET
  • 227.450
  • -0.280-0.12%
Post 20:01 ET
402.35BMarket Cap112.18P/E (TTM)

About AbbVie Company

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Company Profile

SymbolABBV
Company NameAbbVie
Listing DateDec 10, 2012
ISINUS00287Y1091
Founded2011
CEOMr. Robert A. Michael
MarketNYSE
Employees57000
Fiscal Year Ends12-31
Address1 North Waukegan Road
CityNorth Chicago
ProvinceIllinois
CountryUnited States of America
Zip Code60064-6400
Phone1-847-932-7900
Websitehttp://www.abbvie.com

Company Executives

  • Name
  • Position
  • Salary
  • Robert A. Michael
  • Chairman of the Board and Chief Executive Officer
  • 32.53M
  • Scott T. Reents
  • Executive Vice President and Chief Financial Officer
  • 12.35M
  • Jeffrey Ryan Stewart
  • Executive Vice President and Chief Commercial Officer
  • 15.44M
  • Demetris D. Crum
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Dr. Roopal Thakkar, M.D.
  • Executive Vice President, Research and Development and Chief Scientific Officer
  • 9.91M
  • Dr. Nicholas J. Donoghoe, M.D.
  • Executive Vice President, Chief Business and Strategy Officer
  • --
  • Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD
  • Executive Vice President and Chief Operations Officer
  • 10.79M
  • David R. Purdue
  • Principal Accounting Officer, Senior Vice President and Controller
  • --
  • Perry C. Siatis
  • Executive Vice President, General Counsel and Secretary
  • --
  • Roxanne S. Austin
  • Lead Independent Director
  • 432.88K
  • Rebecca B. Roberts
  • Independent Director
  • 372.88K
  • Melody B. Meyer
  • Independent Director
  • 407.88K
  • Jennifer L. Davis
  • Independent Director
  • 372.88K
  • William H.L. Burnside
  • Independent Director
  • 382.88K
  • Thomas J. Falk
  • Independent Director
  • 328.71K
  • Thomas C. Freyman
  • Independent Director
  • 397.88K
  • Frederick H. Waddell
  • Independent Director
  • 402.88K
  • Edward J. Rapp
  • Independent Director
  • 383.44K
  • Brett J. Hart
  • Independent Director
  • 397.88K
  • Dr. Susan E. Quaggin, M.D.
  • Independent Director
  • 359.51K
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +11.05%
Sample Name
Sample Code
 +1.03%
Sample Name
Sample Code
 -2.29%
4
VanEck Oil Services ETF
OIH
-3.00%
5
ProShares Ultra Energy
DIG
-3.15%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.02%
Sample Name
Sample Code
 +9.96%
Sample Name
Sample Code
 +9.80%
4
Qifu Technology
QFIN
+5.99%
5
Futu Holdings Ltd
FUTU
+5.64%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -